Health Care & Life Sciences » Pharmaceuticals | Beijing Leadman Biochemistry Co. Ltd.

Beijing Leadman Biochemistry Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
110,072.00
143,720.20
178,122.70
91,629.60
101,019.40
62,159.80
Depreciation, Depletion & Amortization
16,852.00
45,461.00
53,164.10
42,017.60
39,605.70
42,068
Other Funds
38,509.00
20,219.50
4,564.30
92.00
16,654.30
32,497.30
Funds from Operations
131,335.40
212,652.90
236,370.60
148,130.80
163,429.60
133,003.50
Changes in Working Capital
32,854.10
218,240.00
73,190.40
74,194.60
42,464.40
58,313.20
Net Operating Cash Flow
98,481.30
5,587.10
163,180.20
73,936.20
120,965.20
74,690.30
Capital Expenditures
153,344.60
19,164.90
24,725.00
23,309.60
10,902.30
Sale of Fixed Assets & Businesses
-
6.30
-
-
88.10
Net Investing Cash Flow
153,344.60
145,842.30
24,725.00
23,309.60
10,814.20
Cash Dividends Paid - Total
-
21,504.00
40,152.30
41,947.90
4,236.70
Issuance/Reduction of Debt, Net
10,000.00
69,775.90
30,072.90
13,162.90
16,606.00
Net Financing Cash Flow
48,509.00
71,060.40
65,660.80
28,693.00
4,285.00
Net Change in Cash
103,372.30
222,489.80
72,794.40
21,933.60
105,866.00
Free Cash Flow
54,863.30
24,752.00
138,455.20
50,626.60
110,062.90
Deferred Taxes & Investment Tax Credit
559.90
5,210.70
3,742.90
548.40
467.30
3,721.60
Net Assets from Acquisitions
-
126,683.70
-
-
-

About Beijing Leadman Biochemistry Co.

View Profile
Address
No. 5 Xinghai Road
Beijing Beijing 100176
China
Employees -
Website http://www.leadmanbio.com
Updated 07/08/2019
Beijing Leadman Biochemistry Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. Its main businesses include in vitro diagnostic reagents, diagnostic equipment, and biochemical raw materials businesses. Its In Vitro Diagnostic Reagents business offers immuno-diagnostic chemiluminescent reagents, hemagglutination reagents, and molecular diagnostic reagents.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.